semaglutide news november 28 2025 Good news, trypanophobics (people afraid of needles). Novo Nordisk now offers a weight-loss drug that's a little easier to swallow. The drugmaker announced today it's launching its daily Wegovy pill in the When Joshua Hunt (@viajoshhunt) started

Tesamorelin has randomized human trials and FDA approval for reducing excess abdominal fat in adults with HIV-associated lipodystrophy

GLP-1 drugs, used for diabetes and obesity, may reduce substance addictions

It is dedicated to (i) reviewing the progress made during the first four weeks, (ii) identifying any obstacles to treatment, (iii) revisiting the personal formulation, and (iv) planning the next steps in treatment

You want progress to feel personal and encouraging, not like a score or ranking compared with other people

Combined application of cell therapy GLP-1RA combined with stem cell therapy (such as VX-880 for type 1 diabetes) or gene editing technology (such as CRISPR-Cas9 modified GLP1R gene) may achieve cell regeneration and permanent functional recovery, and fundamentally correct the imbalance of energy distribution